3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10
Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Pain, Postoperative
3
Neurotoxicity Syndromes
3
Melanoma
3
Leukemia, Myeloid, Acute
3
Brain Neoplasms
3
Recurrence
2
Ovarian Neoplasms
2
Hemorrhage
2
Chronic Pain
2
Agnosia
2
Vulvodynia
1
Uterine Cervical Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Seizures
1
Radiodermatitis
1
Radiation Injuries
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Parathyroid Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Interventions
Doxorubicin
6
Vincristine
4
Liposomes
4
Bleomycin
4
Fluorouracil
3
Watchful Waiting
2
Light Coagulation
2
Imiquimod
2
sargramostim
1
Zidovudine
1
Vaccines
1
Sodium Chloride
1
Papillomavirus Vaccines
1
Observation
1
Methotrexate
1
Leucovorin
1
Laser Therapy
1
Isotretinoin
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Fluconazole
1
Dexamethasone
1
Daunorubicin
1
Cytarabine
1
Cyclophosphamide
1
Circumcision, Male
1
Amphotericin B
1
Allopurinol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
HIV Infections
×
Sodium Chloride
×
Clear all
NCT03284866
2026-01-28
COVENANT
AIDS Malignancy Consortium
Phase 3
Completed
536 enrolled